Early Intervention in COVID-19: Favipiravir Verses Standard Care
Status:
Active, not recruiting
Trial end date:
2021-06-25
Target enrollment:
Participant gender:
Summary
Currently we do not know how best to treat patients infected with COVID-19. This study is
looking at whether randomising participants to either favipiravir or to usual care, can help
patients with suspected or proven COVID-19 infection.
Phase:
Phase 3
Details
Lead Sponsor:
Chelsea and Westminster NHS Foundation Trust
Collaborators:
FUJIFILM Toyama Chemical Co., Ltd. Imperial College London NEAT ID Foundation Universitaire Ziekenhuizen Leuven